MAPT and Alzheimer disease: Moreover, we had shown that the Aβ peptide and abnormally hyperphosphorylated tau protein may act synergistically to trigger mitochondrial dysfunction in a triple transgenic mouse model of AD (tripleAD) obtained after crossing P301L tau transgenic mice with APPswPS2 double-transgenic mice [36].